Xconomy’s Digital Events →
Sponsored · Whitepaper
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders
Virtual/hybrid trials and decentralized research can better integrate healthcare into patients’ lives and accelerate approval of new medications
© 2007-2022, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.